Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$225K |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$208K |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$176K |
| 4 |
Tesla
TSLA
|
+$176K |
| 5 |
Meta Platforms (Facebook)
META
|
+$174K |
Top Sells
| 1 |
TECD
Tech Data Corp
TECD
|
+$186M |
| 2 |
MINI
Mobile Mini Inc
MINI
|
+$92.3M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$91.9M |
| 4 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$77.9M |
| 5 |
Kraft Heinz
KHC
|
+$60.1M |
Sector Composition
| 1 | Healthcare | 15.67% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Technology | 11.33% |
| 4 | Industrials | 10.91% |
| 5 | Financials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
International Flavors & Fragrances
IFF
$17B
| $5.43K | 0.01% |
44,371
-166,441
| -79% | -$20.4K |
|
1327
Moody's
MCO
$90.8B
| $5.43K | 0.01% |
18,734
-1,288
| -6% | -$373 |
|
1328
Stride
LRN
$6.89B
| $5.41K | 0.01% |
+205,553
| New | +$5.41K |
|
1329
Kiniksa Pharmaceuticals
KNSA
$2.68B
| $5.41K | 0.01% |
353,029
+130,783
| +59% | +$2K |
|
1330
Skechers
SKX
$9.5B
| $5.4K | 0.01% |
178,633
+29,986
| +20% | +$906 |
|
|
VBIV
1331
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $5.39K | 0.01% |
62,776
+46,358
| +282% | +$3.98K |
|
1332
Vulcan Materials
VMC
$38.9B
| $5.38K | 0.01% |
39,723
-99,563
| -71% | -$13.5K |
|
|
RMO
1333
DELISTED
Romeo Power, Inc.
RMO
| $5.35K | 0.01% |
+499,998
| New | +$5.35K |
|
1334
Floor & Decor
FND
$9.16B
| $5.33K | 0.01% |
71,199
+46,159
| +184% | +$3.45K |
|
1335
Matsons
MATX
$3.28B
| $5.32K | 0.01% |
132,705
-4,438
| -3% | -$178 |
|
1336
ProPetro Holding
PUMP
$506M
| $5.31K | 0.01% |
1,307,778
-176,037
| -12% | -$715 |
|
1337
Ormat Technologies
ORA
$5.56B
| $5.31K | 0.01% |
89,764
+1,620
| +2% | +$96 |
|
1338
Kinross Gold
KGC
$28.3B
| $5.3K | 0.01% |
601,016
-1,975,906
| -77% | -$17.4K |
|
|
NEWR
1339
DELISTED
New Relic, Inc.
NEWR
| $5.3K | 0.01% |
93,952
-20,671
| -18% | -$1.17K |
|
1340
Corteva
CTVA
$48.7B
| $5.29K | 0.01% |
183,768
-1,169,255
| -86% | -$33.7K |
|
|
ISEE
1341
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.29K | 0.01% |
937,341
+14,377
| +2% | +$81 |
|
1342
Abercrombie & Fitch
ANF
$4.44B
| $5.29K | 0.01% |
379,389
-340,015
| -47% | -$4.74K |
|
1343
AMN Healthcare
AMN
$751M
| $5.29K | 0.01% |
90,399
+67,247
| +290% | +$3.93K |
|
|
TIG
1344
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $5.28K | 0.01% |
+345,993
| New | +$5.28K |
|
1345
Vroom, Inc. Common Stock
VRM
$131M
| $5.27K | 0.01% |
1,271
+313
| +33% | +$1.3K |
|
|
CLDR
1346
DELISTED
Cloudera, Inc.
CLDR
| $5.21K | 0.01% |
478,656
+388,795
| +433% | +$4.23K |
|
1347
Mercury Insurance
MCY
$4.31B
| $5.21K | 0.01% |
125,978
+72,028
| +134% | +$2.98K |
|
|
BEST
1348
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $5.21K | 0.01% |
86,819
-14,327
| -14% | -$860 |
|
1349
AngloGold Ashanti
AU
$33.1B
| $5.2K | 0.01% |
197,266
-151,663
| -43% | -$4K |
|
1350
Sangamo Therapeutics
SGMO
$160M
| $5.2K | 0.01% |
+550,732
| New | +$5.2K |
|